0001179110-13-013747.txt : 20130903 0001179110-13-013747.hdr.sgml : 20130902 20130903180726 ACCESSION NUMBER: 0001179110-13-013747 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130829 FILED AS OF DATE: 20130903 DATE AS OF CHANGE: 20130903 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Actavis, Inc. CENTRAL INDEX KEY: 0000884629 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 953872914 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: MORRIS CORPORATE CENTER III STREET 2: 400 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 9092701400 MAIL ADDRESS: STREET 1: MORRIS CORPORATE CENTER III STREET 2: 400 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 FORMER COMPANY: FORMER CONFORMED NAME: WATSON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BUCHEN DAVID A CENTRAL INDEX KEY: 0001241751 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13305 FILM NUMBER: 131076170 4 1 edgar.xml FORM 4 - X0306 4 2013-08-29 0 0000884629 Actavis, Inc. ACT 0001241751 BUCHEN DAVID A MORRIS CORPORATE CENTER III 400 INTERPACE PKWY PARSIPPANY NJ 07054 0 1 0 0 Chief Legal Officer-Global&Sec Common Stock, par value $0.0033 2013-08-29 4 M 0 5000 35.11 A 102373 D Common Stock, par value $0.0033 2013-08-29 4 M 0 5000 25.64 A 107373 D Common Stock, par value $0.0033 2013-08-29 4 S 0 10000 135.5579 D 97373 D Options to Purchase Common Stock 35.11 2013-08-29 4 M 0 5000 0 D 2015-08-12 Common Stock, par value $0.0033 5000 0 D Options to Purchase Common Stock 25.64 2013-08-29 4 M 0 5000 0 D 2016-09-01 Common Stock, par value $0.0033 5000 0 D Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Actavis, Inc., as amended The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.50 to $135.79, inclusive. The reporting person undertakes to provide to Actavis, Inc., any security holder of Actavis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. Vested in four equal annual installments commencing on August 12, 2006. Vested in four equal annual installments commencing on September 1, 2007. /s/DAVID A. BUCHEN 2013-09-03